- Home
- IMNN vs SCNX Comparison
IMNN vs SCNX Comparison
Compare IMNN & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- SCNX
- Stock Information
- Founded
- IMNN 1982
- SCNX 2010
- Country
- IMNN United States
- SCNX United States
- Employees
- IMNN N/A
- SCNX N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- SCNX Other Pharmaceuticals
- Sector
- IMNN Health Care
- SCNX Health Care
- Exchange
- IMNN Nasdaq
- SCNX Nasdaq
- Market Cap
- IMNN 12.2M
- SCNX 59.2M
- IPO Year
- IMNN 1985
- SCNX 2020
- Fundamental
- Price
- IMNN $0.83
- SCNX $7.58
- Analyst Decision
- IMNN Strong Buy
- SCNX
- Analyst Count
- IMNN 2
- SCNX 0
- Target Price
- IMNN $20.50
- SCNX N/A
- AVG Volume (30 Days)
- IMNN 355.1K
- SCNX 12.3K
- Earning Date
- IMNN 11-07-2024
- SCNX 02-10-2025
- Dividend Yield
- IMNN N/A
- SCNX N/A
- EPS Growth
- IMNN N/A
- SCNX N/A
- EPS
- IMNN N/A
- SCNX 3.55
- Revenue
- IMNN N/A
- SCNX N/A
- Revenue This Year
- IMNN N/A
- SCNX $1,085.75
- Revenue Next Year
- IMNN N/A
- SCNX N/A
- P/E Ratio
- IMNN N/A
- SCNX $3.40
- Revenue Growth
- IMNN N/A
- SCNX 166.67
- 52 Week Low
- IMNN $0.48
- SCNX $3.69
- 52 Week High
- IMNN $3.65
- SCNX $44.56
- Technical
- Relative Strength Index (RSI)
- IMNN 47.27
- SCNX N/A
- Support Level
- IMNN $0.80
- SCNX N/A
- Resistance Level
- IMNN $0.88
- SCNX N/A
- Average True Range (ATR)
- IMNN 0.05
- SCNX 0.00
- MACD
- IMNN 0.00
- SCNX 0.00
- Stochastic Oscillator
- IMNN 25.00
- SCNX 0.00
About IMNN Imunon Inc.
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.